STAA Staar Surgical Co

  1. Stocks
  2. Healthcare
  3. NASDAQ: STAA

Price (delayed)

$40.09

Market cap

$1.97B

P/E Ratio

125.28

Dividend/share

N/A

EPS

$0.32

Enterprise value

$1.78B

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are ...

Highlights
Staar Surgical's equity has increased by 16% YoY
The revenue has grown by 11% YoY
STAA's P/E is 34% below its 5-year quarterly average of 191.2 but 33% above its last 4 quarters average of 95.3
Staar Surgical's EPS has shrunk by 53% YoY and by 27% QoQ
Staar Surgical's net income has plunged by 53% YoY and by 28% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.staar.com
Peers: COO ATRI ABT IRIX

Key stats

What are the main financial stats of STAA
Market
Shares outstanding
49.13M
Market cap
$1.97B
Enterprise value
$1.78B
Valuations
Price to earnings (P/E)
125.28
Price to book (P/B)
4.99
Price to sales (P/S)
6.01
EV/EBIT
90.06
EV/EBITDA
71.19
EV/Sales
5.46
Earnings
Revenue
$326.24M
EBIT
$19.78M
EBITDA
$25.02M
Free cash flow
$20.88M
Per share
EPS
$0.32
Free cash flow per share
$0.43
Book value per share
$8.04
Revenue per share
$6.67
TBVPS
$10.03
Balance sheet
Total assets
$492.54M
Total liabilities
$99.75M
Debt
$35.7M
Equity
$392.79M
Working capital
$303.04M
Liquidity
Debt to equity
0.09
Current ratio
5.84
Quick ratio
4.94
Net debt/EBITDA
-7.53
Margins
EBITDA margin
7.7%
Gross margin
78.5%
Net margin
4.7%
Operating margin
7.1%
Efficiency
Return on assets
3.2%
Return on equity
4%
Return on invested capital
6.8%
Return on capital employed
4.6%
Return on sales
6.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STAA stock price

How has the Staar Surgical stock price performed over time
Intraday
-1.43%
1 week
-5.67%
1 month
-11.91%
1 year
-28.45%
YTD
28.45%
QTD
-15.8%

Financial performance

How have Staar Surgical's revenue and profit performed over time
Revenue
$326.24M
Gross profit
$256.12M
Operating income
$23.02M
Net income
$15.3M
Gross margin
78.5%
Net margin
4.7%
Staar Surgical's net margin has plunged by 58% YoY and by 29% from the previous quarter
Staar Surgical's net income has plunged by 53% YoY and by 28% from the previous quarter
Staar Surgical's operating margin has decreased by 39% YoY and by 18% from the previous quarter
STAA's operating income is down by 33% year-on-year and by 18% since the previous quarter

Growth

What is Staar Surgical's growth rate over time

Valuation

What is Staar Surgical stock price valuation
STAA P/E details
P/E
125.28
P/B
4.99
P/S
6.01
EV/EBIT
90.06
EV/EBITDA
71.19
EV/Sales
5.46
Staar Surgical's EPS has shrunk by 53% YoY and by 27% QoQ
STAA's P/E is 34% below its 5-year quarterly average of 191.2 but 33% above its last 4 quarters average of 95.3
STAA's price to book (P/B) is 60% lower than its 5-year quarterly average of 12.6 and 4.5% lower than its last 4 quarters average of 5.3
Staar Surgical's equity has increased by 16% YoY
The stock's price to sales (P/S) is 58% less than its 5-year quarterly average of 14.6 and 3.2% less than its last 4 quarters average of 6.3
The revenue has grown by 11% YoY

Efficiency

How efficient is Staar Surgical business performance
Staar Surgical's return on assets has shrunk by 61% YoY and by 32% QoQ
The ROE has plunged by 60% YoY and by 32% from the previous quarter
The ROIC has plunged by 52% YoY and by 22% from the previous quarter
Staar Surgical's return on sales has shrunk by 50% YoY and by 27% QoQ

Dividends

What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STAA.

Financial health

How did Staar Surgical financials performed over time
Staar Surgical's total liabilities has increased by 25% YoY but it has decreased by 2.9% from the previous quarter
The total assets is up by 18% year-on-year
Staar Surgical's debt is 91% less than its equity
Staar Surgical's equity has increased by 16% YoY
Staar Surgical's debt has increased by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.